Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway is a research paper published in Journal of Neuro-Oncology (2021). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R21NS107879
National Institutes of Health
Grant: P01CA093900
University of Michigan Rogel Cancer Center
Grant: G020989
U.S. Department of Defense
Grant: PC170089
U.S. Department of Veterans Affairs
Grant: 1I01BX001370
National Institutes of Health
Grant: 5P01CA093900-10
Administrative Core
National Institutes of Health
Grant: 2I01BX001370-05A2
Convergence of Endothelin-1 and Androgen Signaling in Prostate Cancer Bone Metastasis
National Institutes of Health
Grant: 1R21NS107879-01
Engineering stem cells as diagnostic and therapeutic agents for glioblastoma
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals